oleic acid and losartan

oleic acid has been researched along with losartan in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Dumont, CJ; Grekin, RJ; Vollmer, AP; Watts, SW; Webb, RC1
Downton, M; Du, Y; Jia, Z; Liu, G; Liu, S; Liu, Y; Yang, T1
Chuang, PY; He, JC; Menon, MC1

Other Studies

4 other study(ies) available for oleic acid and losartan

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mechanisms in the pressor effects of hepatic portal venous fatty acid infusion.
    The American journal of physiology, 1997, Volume: 273, Issue:1 Pt 2

    Topics: Acetylcholine; Aldosterone; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Corticosterone; Epinephrine; Fatty Acids, Nonesterified; Heart Rate; Hypertension; Imidazoles; Infusions, Intravenous; Liver; Losartan; Male; Norepinephrine; Oleic Acid; Phenylephrine; Portal Vein; Prazosin; Rats; Rats, Sprague-Dawley; Renin; Serotonin; Sodium Fluoride; Tetrazoles; Time Factors

1997
Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice.
    American journal of physiology. Renal physiology, 2013, Dec-01, Volume: 305, Issue:11

    Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Humans; Losartan; Mice; Mice, Inbred C57BL; Oleic Acid; Renin-Angiotensin System

2013
Nitro-oleic acid is a novel anti-oxidative therapy for diabetic kidney disease.
    American journal of physiology. Renal physiology, 2013, Dec-01, Volume: 305, Issue:11

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Diabetic Nephropathies; Humans; Losartan; Oleic Acid

2013